They are most commonly identified using specific cell-surface antigens like CD44, CD133 and CD24 together with implantation and tumor sphere formation assays to prove their ability to initiate a tumor containing the same CSCs as well as differentiated progeny [20]. The gene discussed is CD24; the disease is neoplasm.